Catheter Related Infections (CRI)

  • Antimicrobial Catheter Lock System
  • Provide Patency and Infection Control

Catheter lock solutions for patients in various contexts.
TauroLock™-U25.000 provides a particularly strong prophylaxis against occlusion, as urokinase serves to break up blood clotting.

  • antimicrobial to prevent infections
  • antibiofilm to keep catheters clean
  • antiocclusive to maintain a good flow rate

TauroLock™-U25.000 has been approved for instillation in all central-venous access systems. This lock solution reliably prevents the formation of bacterial biofilms within catheters. As a result, patients can avoid infections and maintain a high patency rate.

TauroLock™-U25.000 is based on three active ingredients:
citrate (4 %)
urokinase (25,000 units)

Taurolidine has a broad antimicrobial activity (incl. MRSA and VRE), while citrate works as an anticoagulant. At the same time, urokinase yields a thrombolytic effect.

Before applying TauroLock™-U25.000, dissolve the vial’s content (i.e. 25,000 IU urokinase) with 5 ml of TauroLock™. In-between treatment sessions, TauroLock™-U25.000 is instilled into the vascular access system. Please note that medical staff must check the filling volume of the respective catheter or port system.